Skip to content
Live Report from ASH: Azacitidine ‘New Standard’ In High Risk Myelodysplastic Syndromes

Live Report from ASH: Azacitidine ‘New Standard’ In High Risk Myelodysplastic Syndromes

Get the podcast

Pierre Fenaux PIERRE FENAUX, Paris 13 University Results from a phase III study presented at ASH suggest that the hypomethylating agent azacitidine should be the new standard of care for patients with

The Audio Journal of Oncology
Pierre Fenaux

Pierre Fenaux

PIERRE FENAUX, Paris 13 UniversityResults from a phase III study presented at ASH suggest that the hypomethylating agent azacitidine should be the new standard of care for patients with high-risk MDS.Pierre Fenauxof Paris 13 University gave the details to Derek Thorne.

Tags

agentashmyelodysplasticNewspatientpodcastpodcastingpresentedreportreportsriskstudysyndrome

Next in ASH 2007

All 11 interviews

Interview 8 of 11

Live Report from ASH:<br />Interleukin-2 For Acute Myeloid Leukemia In First Remission?

Live Report from ASH:<br />Interleukin-2 For Acute Myeloid Leukemia In First Remission?

Jonathan Kolitz JONATHAN KOLITZ, Monter Cancer Center, Lake Success, NY GEORGE CANELLOS, Dana-Farber Cancer Institute For patients with acute myeloid leukemia in first remission, new data suggests tha

10 December 2007

Related Episodes

New Front Line Standard for Older Patients with Chronic Lymphocytic Leukemia

New Front Line Standard for Older Patients with Chronic Lymphocytic Leukemia

Audio Journal of Oncology SAN DIEGO—The first-line treatment of choice for older patients with chronic lymphocytic leukemia (CLL) should now be single agent ibrutinib according to conclu

24 Jan 2020
3 min
Ibrutinib: New Frontline Standard for Chronic Lymphocytic Leukemia?

Ibrutinib: New Frontline Standard for Chronic Lymphocytic Leukemia?

SAN DIEGO—Patients 70 years old and younger with previously untreated chronic lymphocytic leukemia (CLL) lived longer and had progression of their disease delayed when treated with ibrutinib (an irrev

7 Oct 2019
10 min
Audio Journal of Oncology Volume 16 Number 11

Audio Journal of Oncology Volume 16 Number 11

Scientific Editors: George Canellos (Boston), Pat Price (Manchester), Gianni Bonadonna (Milan), Gordon McVie (Milan) Sarah Maxwell and Peter Goodwin report from: American Society of Clinical Oncology

3 Jun 2008